Investment Portfolio News
MONCTON, NB – April 24, 2013 – Picomole Inc. (“Picomole”), the world leader in infrared technologies for breath analysis, announced today that it has developed a diagnostic test to detect lung cancer that has a preliminary accuracy of 98.5%. This best-in-class result is better than any other technique currently in use for the detection of lung cancer.
Keep checking back often for media coverage of VA Angels’ Portfolio Company. This page will be updated as our Portfolio Companies get coverage in the media.